Stocklytics Platform
NUVO
Nuvo Group Ltd.
NUVO3
$0.000.00%$0.00
Penny Stock
NUVO
NUVO3

$0.00

0.00%

Performance History

Chart placeholder
Key Stats
Open$0.00
Prev. Close$0.00
EPS-1.01
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$5.65M
PE Ratio-
LOWHIGH
Day Range0.00
0.00
52 Week Range0.00
8.56
Ratios
Revenue-
EBITDA Margin %-
EPS-1.01

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Nuvo Group Ltd. (NUVO)

Nuvo Group Ltd. (NUVO) is a company that specializes in developing innovative healthcare solutions. The company's primary focus is on providing non-invasive monitoring devices for chronic conditions such as diabetes. With a strong emphasis on research and development, Nuvo Group Ltd. is constantly striving to push the boundaries of medical technology.
One of the key strengths of Nuvo Group Ltd. is its stock price history. Over the years, the company has shown consistent growth in its stock price, which is a testament to its strong market position and financial stability. Investors who have invested in NUVO stock have been rewarded with significant returns, making it an attractive investment option.
In addition to its stock price history, Nuvo Group Ltd. also has a solid market cap. The company's market capitalization is an indicator of its overall value and is calculated by multiplying its stock price by the number of outstanding shares. NUVO's market cap is a reflection of investor confidence in the company and its future prospects.
One of the key metrics used by investors to assess the value of a stock is the PEG ratio. The PEG ratio is calculated by dividing a company's price-to-earnings ratio (P/E ratio) by its expected earnings growth rate. A PEG ratio of less than 1 is generally considered undervalued, while a ratio greater than 1 may indicate an overvalued stock. NUVO's PEG ratio is an important factor to consider when evaluating its investment potential.
When comparing Nuvo Group Ltd. to the industry, it is important to analyze its performance relative to its peers. NUVO has been able to establish a strong position within the healthcare industry, outperforming many of its competitors. This can be attributed to its focus on innovation and its ability to develop and commercialize cutting-edge technologies.
Furthermore, it is essential to consider NUVO's 52-week range when assessing its performance. The 52-week range represents the highest and lowest prices at which the stock has traded over the past year. This range is often used by investors to gauge the stock's volatility and potential for future growth. NUVO's 52-week range provides valuable insights into its performance and investor sentiment.
Finally, NUVO's trading volume is another important factor to consider. Trading volume refers to the number of shares that are bought and sold in a given period. High trading volume is often an indication of investor interest and can contribute to increased liquidity in the stock. NUVO's trading volume can provide valuable insights into market sentiment and can help investors make informed decisions.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NYSE
add Nuvo Group Ltd. to watchlist

Keep an eye on Nuvo Group Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Nuvo Group Ltd.'s (NUVO) price per share?

The current price per share for Nuvo Group Ltd. (NUVO) is $0.01. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Nuvo Group Ltd. (NUVO)?

For Nuvo Group Ltd. (NUVO), the 52-week high is $8.56, which is 137.96K% from the current price. The 52-week low is $0, the current price is 55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Nuvo Group Ltd. (NUVO) a growth stock?

Nuvo Group Ltd. (NUVO) has shown an average price growth of -4.13% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nuvo Group Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Nuvo Group Ltd. (NUVO) stock price performance year to date (YTD)?

As of the latest data, Nuvo Group Ltd. (NUVO) has a year-to-date price change of . Over the last three months, the change has been -97.7%. Over the past six months, the figure is -99.63%.
help

Is Nuvo Group Ltd. (NUVO) a profitable company?

Nuvo Group Ltd. (NUVO) has a net income of -$3.49M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -17.52K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.65M. Furthermore, the EBITDA is -$24.02M.
help

What is the market capitalization of Nuvo Group Ltd. (NUVO)?

Nuvo Group Ltd. (NUVO) has a market capitalization of $5.65M. The average daily trading volume is 2.24K, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level